Published in Johns Hopkins Med J on June 01, 1972
Mechanism of trapping of immune complexes in joint collagenous tissues. Clin Exp Immunol (1975) 1.38
Bovine serum albumin chronic serum sickness nephropathy in rats. Br J Exp Pathol (1978) 0.90
The mesangium in glomerular disease. Proc R Soc Med (1975) 0.81
Serial study of phagocytic function in rat bovine serum albumin (BSA) nephritis. Br J Exp Pathol (1988) 0.75
Demonstration of immune complex deposits by electron microscopy and immunofluorescence in a fatal case of hypersensitivity angiitis. Can Med Assoc J (1978) 0.75
Increased atherosclerosis and glomerulonephritis in cynomolgus monkeys (Macaca fascicularis) given injections of BSA over an extended period of time. Am J Pathol (1983) 0.75
Experimental glomerulonephritis induced by human IgG in rats. Clin Exp Immunol (1984) 0.75
The observation of immune complex formation and deposition in the eyes of living rabbits. Clin Exp Immunol (1987) 0.75
Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant. Science (1990) 6.77
Induction of anti-HIV neutralizing antibodies by synthetic peptides. EMBO J (1986) 4.32
Spectrum of human cytomegalovirus complement-fixing antigens. J Immunol (1967) 3.03
Defective virions of herpes simplex viruses. Intervirology (1973) 3.03
Antibody to hepatitis B surface antigen after a single inoculation of uncoupled synthetic HBsAg peptides. Nature (1982) 3.01
Assay of Australia antigen and antibody employing double-antibody and solid-phase radioimmunoassay techniques and comparison with the passive hemagglutination methods. J Immunol (1971) 2.35
Antiserum to a synthetic peptide recognizes the HTLV-III envelope glycoprotein. Science (1986) 2.33
Detection of hepatitis A viral antigen by radioimmunoassay. J Immunol (1975) 2.33
Utilization of the biotin/avidin system to amplify the sensitivity of the enzyme-linked immunosorbent assay (ELISA). J Immunol Methods (1983) 2.28
Cytomegalovirus antigen within human arterial smooth muscle cells. Lancet (1983) 2.13
Immune complex disease. V. The nature of the circulating complexes associated with glomerular alterations in the chronic BSA-rabbit system. Johns Hopkins Med J (1972) 1.74
Passive immune complex glomerulonephritis in mice: models for various lesions found in human disease. II. Low avidity complexes and diffuse proliferative glomerulonephritis with subepithelial deposits. Lab Invest (1979) 1.74
Biophysical and biochemical heterogeneity of purified hepatitis B antigen. J Virol (1972) 1.70
Antibody-dependent enhancement of human immunodeficiency virus type 1 (HIV-1) infection in vitro by serum from HIV-1-infected and passively immunized chimpanzees. Proc Natl Acad Sci U S A (1989) 1.64
Passive immune complex glomerulonephritis in mice: models for various lesions found in human disease. I. High avidity complexes and mesangiopathic glomerulonephritis. Lab Invest (1979) 1.54
Immune response to hepatitis B surface antigen: enhancement by prior injection of antibodies to the idiotype. Science (1983) 1.48
Production of potent anti-Australia antigen sera of high specificity and sensitivity in goats. Infect Immun (1972) 1.41
Immune complex disease. I. Experimental acute and chronic glomerulonephritis. Johns Hopkins Med J (1967) 1.41
A unique influence of cortisone on the transit of specific macromolecules across vascular walls in immune complex disease. Johns Hopkins Med J (1968) 1.40
Common idiotypic determinant associated with human antibodies to hepatitis B surface antigen. J Immunol (1983) 1.38
Cellular and humoral immunity in guinea pigs to two major polypeptides derived from hepatitis B surface antigen. J Gen Virol (1978) 1.37
Biotin-avidin-amplified enzyme immunoassay for detection of herpes simplex virus antigen in clinical specimens. J Clin Microbiol (1983) 1.36
Enhancement of the immune response to hepatitis B surface antigen. In vivo administration of antiidiotype induces anti-HBs that expresses a similar idiotype. J Exp Med (1984) 1.35
Expression of herpesvirus-induced antigens in human cervical cancer. Nature (1980) 1.29
Comparative biophysical studies of hepatitis B antigen, subtypes adw and ayw. J Virol (1975) 1.29
Herpesvirus-induced antigens in squamous-cell carcinoma in situ of the vulva. N Engl J Med (1981) 1.25
Anti-idiotypic antibody vaccine for type B viral hepatitis in chimpanzees. Science (1986) 1.24
The effect of antigen excess on chronic immune complex glomerulonephritis. Johns Hopkins Med J (1969) 1.23
Immune complex disease. II. The role of circulatory dynamics and glomerular filtration in the development of experimental glomerulonephritis. Johns Hopkins Med J (1967) 1.19
Detection of viral hepatitis type A. Am J Clin Pathol (1976) 1.17
Evidence for the presence of repeating antigenic determinants in the major polypeptides derived from hepatitis B surface antigen. Virology (1981) 1.17
Reductive dissociation of chicken gamma-G immunoglobulin in neutral solvents without a dispersing agent. Proc Natl Acad Sci U S A (1965) 1.15
Application of a modified computer algorithm in determining potential antigenic determinants associated with the AIDS virus glycoprotein. Anal Biochem (1985) 1.15
Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant: further clarifications. Science (1991) 1.14
Detection of herpesvirus type-specific antibody by a micro solid phase radioimmunometric assay. Intervirology (1979) 1.14
Production of antibody to individual polypeptides derived from purified hepatitis B surface antigen. J Virol (1975) 1.12
Studies on herpes simplex virus and cancer. Cancer Res (1976) 1.12
Induction of an anti-hepatitis B surface antigen response in mice by noninternal image (Ab2 alpha) anti-idiotypic antibodies. J Immunol (1987) 1.11
Biophysical and biochemical properties of purified preparations of hepatitis B surface antigen (HBs Ag). Am J Med Sci (1976) 1.11
Glycoproteins associated with hepatitis B antigen. Intervirology (1973) 1.09
Humoral and cellular immunity to hepatitis B virus-derived antigens: comparative activity of Freund complete adjuvant alum, and liposomes. Infect Immun (1980) 1.09
Antibody to hepatitis B virus induced by injecting antibodies to the idiotype. Science (1984) 1.08
Use of a resin-bound synthetic peptide for identifying a neutralizing antigenic determinant associated with the human immunodeficiency virus envelope. J Biol Chem (1987) 1.07
Glomerular charge and urinary protein excretion: effects of systemic and intrarenal polycation infusion in the rat. Kidney Int (1982) 1.04
Monoclonal anti-idiotypic antibody mimics the CD4 receptor and binds human immunodeficiency virus. Proc Natl Acad Sci U S A (1987) 1.03
Passive immune complex glomerulonephritis in mice. III. Clearance kinetics and properties of circulating complexes. Lab Invest (1982) 1.03
Epitopes associated with a synthetic hepatitis B surface antigen peptide. J Immunol (1983) 1.02
Detection of interspecies idiotypic cross-reactions associated with antibodies to hepatitis B surface antigen. Eur J Immunol (1983) 1.02
Production and characterization of anti-idiotype reagents for the analysis of viral antigen systems. J Virol Methods (1983) 1.01
A prospective study of association of herpes simplex virus and human papillomavirus infection with cervical neoplasia in women exposed to diethylstilbestrol in utero. Int J Cancer (1985) 1.01
Monoclonal antibodies of hybridomas. Rev Infect Dis (1983) 1.01
Expression and characterization of hepatitis B virus surface antigen polypeptides in insect cells with a baculovirus expression system. J Virol (1989) 1.01
Induction of hepatitis B surface antigen in human hepatoma-derived cell lines. J Gen Virol (1981) 1.00
Suppression of in vivo tumor formation induced by simian virus 40-transformed cells in mice receiving antiidiotypic antibodies. J Exp Med (1985) 0.99
Anti-idiotypic antibodies: implications of internal image-based vaccines for infectious diseases. J Infect Dis (1985) 0.98
Posttransfusion hepatitis type A. JAMA (1983) 0.97
Alteration of hepatitis B antigen (HB Ag) determinants by reduction and alkylation. J Gen Virol (1973) 0.96
Approaching the control of viral hepatitis type B. J Infect Dis (1976) 0.95
Antibody to herpes simplex virus type 2-induced nonstructural proteins in women with cervical cancer and in control groups. J Natl Cancer Inst (1975) 0.95
Fatal immune complex glomerulonephritis without deposits. Johns Hopkins Med J (1975) 0.95
Characteristics of a shared idiotype by two IgM anti-herpes simplex virus monoclonal antibodies that recognize different determinants. J Immunol (1983) 0.94
Biophysical properties of purified morphologic forms of hepatitis B antigen. Intervirology (1974) 0.94
Major polar lipids of hepatitis B antigen preparations: evidence for the presence of a glycosphingolipid. J Virol (1974) 0.94
Enzyme potentiated radioimmunoassay (EPRIA): a sensitive third-generation test for the detection of hepatitis B surface antigen. J Immunol Methods (1981) 0.93
Antiidiotype modulation of herpes simplex virus infection leading to increased pathogenicity. J Virol (1984) 0.92
Expression of infectious viral particles by primary chimpanzee hepatocytes isolated during the acute phase of non-A, non-B hepatitis. J Infect Dis (1990) 0.91
Immune response to human immunodeficiency virus. In vivo administration of anti-idiotype induces an anti-gp160 response specific for a synthetic peptide. J Immunol (1987) 0.91
Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant: corrections and clarifications. Science (1991) 0.90
Immune complex disease. VI. Some determinants of the varieties of glomerular lesions in the chronic bovine serum albumin-rabbit system. Lab Invest (1977) 0.89
Biochemical and biophysical properties of hepatitis B core particles derived from Dane particles and infected hepatocytes. Intervirology (1977) 0.89
Immunization of chimpanzees with hepatitis B virus-derived polypeptides. Infect Immun (1981) 0.89
Focal mesangiopathic glomerulonephritis: prevalence and pathogenesis. Kidney Int (1975) 0.88
Immune complex disease. 3. The granulomatous manifestations. Johns Hopkins Med J (1967) 0.88
Coxsackievirus aggregates in muscle cells of a polymyositis patient. Intervirology (1978) 0.87
Heparin therapy in anti-basement membrane nephritis. Kidney Int (1975) 0.87
Subtyping of hepatitis B antigen by use of monospecific antibody-coated cells. J Infect Dis (1973) 0.86
Detection of non-A, non-B hepatitis antigen by immunocytochemical staining. Proc Natl Acad Sci U S A (1984) 0.85
Antigenic relationship of a hepatitis B surface antigen-derived polypeptide and human serum albumin. J Gen Virol (1980) 0.85
Cytotoxicity by NK-like cells from hepatitis B-immune patients to a human hepatoma cell line secreting HBsAg. J Immunol (1983) 0.85
Immunogenicity of conjugates and micelles of synthetic hepatitis B surface antigen peptides. Intervirology (1982) 0.85
Characterization of anti-hepatitis B surface antigen monoclonal antibodies. Intervirology (1983) 0.85
Characterization of the herpes virion. I. Purification and amino acid composition of nucleocapsids. Virology (1972) 0.85
Comparative studies of the immunogenic activity of hepatitis B surface antigen (HBsAg) and HBsAg polypeptides. J Med Virol (1983) 0.84
Radioimmunoassay of human serum antibody specific for adenovirus type 5-purified fiber. J Immunol (1975) 0.84
Papovavirus structural polypeptides: comparison of human and rabbit papilloma viruses with simian virus 40. Intervirology (1974) 0.84
Ultrastructural changes and virus-like particles localized in liver hepatocytes of chimpanzees infected with non-A, non-B hepatitis. J Med Virol (1981) 0.84
Inhibition of a common human anti-hepatitis B surface antigen idiotype by a cyclic synthetic peptide. J Virol (1983) 0.84
Cell-mediated immunity in guinea pigs to subunits derived from hepatitis B surface antigen. Infect Immun (1975) 0.83
Letter: Paramyxovirus-like structures in Goodpasture's syndrome. Lancet (1974) 0.83
Immunological and biophysical alteration of hepatitis B virus antigens by sodium hypochlorite disinfection. Appl Environ Microbiol (1981) 0.82
Effect of alkaline glutaraldehyde on hepatitis B virus antigens. Eur J Clin Microbiol (1983) 0.82
Expression and characterization of hepatitis B virus precore-core antigen in E. coli. Viral Immunol (1987) 0.82
Anti-idiotypic antibodies: a new generation of vaccines against infectious agents. Microbiol Sci (1987) 0.82
Response to a hepatitis B polypeptide vaccine in micelle form in a young adult population. J Med Virol (1986) 0.82
Antibasement membrane disease. I. The glomerular lesions of Goodpasture's disease and experimental disease in sheep. Johns Hopkins Med J (1972) 0.82
Immunohistochemical and electron microscopic detection of hepatitis B surface and core antigens. Exp Mol Pathol (1978) 0.82
Lack of genetic restriction by a potential anti-idiotype vaccine for type B viral hepatitis. Virology (1986) 0.81
Modified radioimmunoassay for murine sarcoma-leukemia virus group-specific antigen. Appl Microbiol (1974) 0.81
Longitudinal study of HTLV-III-infected chimpanzees by lymphocyte subpopulation analysis. J Med Primatol (1985) 0.81